Result: The specificity of the blot was proven by using an additional genome containing the
precore double mutation
G1896A/
G1899A, which was used as an additional
HBeAg negative control, and by using an
HBeAg positive WT genome as a positive control (Figure 3A).
Discussion: Interestingly,
BCP double mutation was found in both
HBeAg-positive and
HBeAg-negative patients, underlining that